Improving therapeutic protein secretion in the probiotic yeast Saccharomyces boulardii using a multifactorial engineering approach
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Improving therapeutic protein secretion in the probiotic yeast Saccharomyces boulardii using a multifactorial engineering approach ; volume:22 ; number:1 ; day:7 ; month:6 ; year:2023 ; pages:1-18 ; date:12.2023
Microbial cell factories ; 22, Heft 1 (7.6.2023), 1-18, 12.2023
- Klassifikation
-
Biowissenschaften, Biologie
- Urheber
-
Durmusoglu, Deniz
Al’Abri, Ibrahim
Li, Zidan
Islam Williams, Taufika
Collins, Leonard B.
Martínez, José L.
Crook, Nathan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12934-023-02117-y
- URN
-
urn:nbn:de:101:1-2023091614454418028390
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Durmusoglu, Deniz
- Al’Abri, Ibrahim
- Li, Zidan
- Islam Williams, Taufika
- Collins, Leonard B.
- Martínez, José L.
- Crook, Nathan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Multifactorial inhibition of Candida albicans by combinations of lactobacilli and probiotic Saccharomyces cerevisiae CNCM I-3856
Heterologous Expression of the Leuconostoc Bacteriocin Leucocin C in Probiotic Yeast Saccharomyces boulardii
New biomarkers underlying acetic acid tolerance in the probiotic yeast Saccharomyces cerevisiae var. boulardii
S-Adenosyl-L-Methionine protects the probiotic yeast, Saccharomyces boulardii,from acid-induced cell death
Production of neoagarooligosaccharides by probiotic yeast Saccharomyces cerevisiae var. boulardii engineered as a microbial cell factory
Experience with Saccharomyces boulardii Probiotic in Oncohaematological Patients
Strain engineering and metabolic flux analysis of a probiotic yeast Saccharomyces boulardii for metabolizing l-fucose, a mammalian mucin component
High level secretion of cellobiohydrolases by Saccharomyces cerevisiae
Oleaginicity of the yeast strain Saccharomyces cerevisiae D5A
Antimicrobial and antioxidant activities of Saccharomyces cerevisiae IFST062013, a potential probiotic
Secretion of collagenases by Saccharomyces cerevisiae for collagen degradation
In Vitro Detoxification of Aflatoxin B1, Deoxynivalenol, Fumonisins, T-2 Toxin and Zearalenone by Probiotic Bacteria from Genus Lactobacillus and Saccharomyces cerevisiae Yeast
Multifactorial inhibition of Candida albicans by combinations of lactobacilli and probiotic Saccharomyces cerevisiae CNCM I-3856
Heterologous Expression of the Leuconostoc Bacteriocin Leucocin C in Probiotic Yeast Saccharomyces boulardii
New biomarkers underlying acetic acid tolerance in the probiotic yeast Saccharomyces cerevisiae var. boulardii
S-Adenosyl-L-Methionine protects the probiotic yeast, Saccharomyces boulardii,from acid-induced cell death
Production of neoagarooligosaccharides by probiotic yeast Saccharomyces cerevisiae var. boulardii engineered as a microbial cell factory
Experience with Saccharomyces boulardii Probiotic in Oncohaematological Patients
Strain engineering and metabolic flux analysis of a probiotic yeast Saccharomyces boulardii for metabolizing l-fucose, a mammalian mucin component
High level secretion of cellobiohydrolases by Saccharomyces cerevisiae
Oleaginicity of the yeast strain Saccharomyces cerevisiae D5A
Antimicrobial and antioxidant activities of Saccharomyces cerevisiae IFST062013, a potential probiotic
Secretion of collagenases by Saccharomyces cerevisiae for collagen degradation
In Vitro Detoxification of Aflatoxin B1, Deoxynivalenol, Fumonisins, T-2 Toxin and Zearalenone by Probiotic Bacteria from Genus Lactobacillus and Saccharomyces cerevisiae Yeast
Multifactorial inhibition of Candida albicans by combinations of lactobacilli and probiotic Saccharomyces cerevisiae CNCM I-3856
Heterologous Expression of the Leuconostoc Bacteriocin Leucocin C in Probiotic Yeast Saccharomyces boulardii
New biomarkers underlying acetic acid tolerance in the probiotic yeast Saccharomyces cerevisiae var. boulardii
S-Adenosyl-L-Methionine protects the probiotic yeast, Saccharomyces boulardii,from acid-induced cell death
Production of neoagarooligosaccharides by probiotic yeast Saccharomyces cerevisiae var. boulardii engineered as a microbial cell factory
Experience with Saccharomyces boulardii Probiotic in Oncohaematological Patients
Strain engineering and metabolic flux analysis of a probiotic yeast Saccharomyces boulardii for metabolizing l-fucose, a mammalian mucin component
High level secretion of cellobiohydrolases by Saccharomyces cerevisiae
Oleaginicity of the yeast strain Saccharomyces cerevisiae D5A
Antimicrobial and antioxidant activities of Saccharomyces cerevisiae IFST062013, a potential probiotic
Secretion of collagenases by Saccharomyces cerevisiae for collagen degradation